Archives

Survey demonstrates that individuals with COPD seek more options to reduce risks of seasonal respiratory viral infections

by Uniseed01 | Jan 31, 2023 | Latest News

— ENA Respiratory and COPD Foundation survey confirms patients are overwhelmingly positive about taking an immune-modulating nasal spray to reduce lung disease exacerbations– — Survey was conducted through COPD360Net®, an innovative...

Ferronova secures A$11 million to advance nanotech image-guided cancer therapy

by Uniseed01 | Jan 23, 2023 | Latest News

23 January 2023 – Uniseed investee Ferronova announced today it has secured a further A$11 million to progress the company’s nanoparticle platform to assist surgeons to more accurately locate and remove malignant cells during treatment of gastrointestinal...

Uniseed Investee Company ENA Respiratory Awarded $4.38 Million U.S. Department of Defense Agreement to Fund Development of Broad-Spectrum Antiviral INNA-051

by Uniseed01 | Jan 10, 2023 | Latest News

— Goal is to add new medical countermeasure (MCM) against known and emerging viral respiratory threats Melbourne, Australia, 9th January 2023 – Clinical-stage pharmaceutical company ENA Respiratory has been awarded a $4.38 million USD agreement...

Survey demonstrates that individuals with COPD seek more options to reduce risks of seasonal respiratory viral infections

Ferronova secures A$11 million to advance nanotech image-guided cancer therapy

Uniseed Investee Company ENA Respiratory Awarded $4.38 Million U.S. Department of Defense Agreement to Fund Development of Broad-Spectrum Antiviral INNA-051

Recent Posts

Recent Comments

Categories

Meta